Results 261 to 270 of about 210,178 (301)
Some of the next articles are maybe not open access.
Reviews in clinical and experimental hematology, 2003
Epidemiologic and molecular observations have recently suggested that hepatitis C virus (HCV) may be the causative agent of some B-cell non-Hodgkin lymphomas (B-NHL). Epidemiologic data suggest that in Italy about 5% of B-NHL are caused by HCV. Molecular data indicate a close relationship between HCV-associated B-NHL and type II mixed cryoglobulinemia.
FIORILLI, Massimo +3 more
openaire +4 more sources
Epidemiologic and molecular observations have recently suggested that hepatitis C virus (HCV) may be the causative agent of some B-cell non-Hodgkin lymphomas (B-NHL). Epidemiologic data suggest that in Italy about 5% of B-NHL are caused by HCV. Molecular data indicate a close relationship between HCV-associated B-NHL and type II mixed cryoglobulinemia.
FIORILLI, Massimo +3 more
openaire +4 more sources
Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
Journal of the Formosan Medical Association, 2021Nien-Tzu Hsu +2 more
exaly
HCV Antigen in anti-HCV positive sera of patients with HCV infection
2002Only ways to detect HCV viremia have beendetection of HCV RNA by nucleid acid amplifying test (NAT). Nats wew sensitive butentails substantial operational complexity and are very expensive for screening. Recently it was developed a sensitive EIA for HCVAg detection during a period when it is free, not bound with antibody, because they were not yet ...
openaire +1 more source
The oncologic burden of hepatitis C virus infection: A clinical perspective
Ca-A Cancer Journal for Clinicians, 2017Nassim Hammoudi +2 more
exaly
Efficacy of HCV core antigen detection during the preseroconversion period
Transfusion, 2000S Laperche, A M Courouce
exaly
Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients
Journal of Clinical Virology, 2010Pr Lionel Rostaing +2 more
exaly